Living Cell Technologies (LHI0) Ratios
Living Cell Technologies Ratios
DE:LHI0's free cash flow for Q3 2025 was $-992.86K. For the 2025 fiscal year, DE:LHI0's free cash flow was increased by $0.00 and operating cash flow was $-992.86K. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 24 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 25.11 | 30.78 | 14.13 | 13.85 | 17.84 |
| Quick Ratio | 24.09 | 30.78 | 14.13 | 13.85 | 17.84 |
| Cash Ratio | 18.04 | 17.42 | 2.76 | 13.63 | 30.26 |
| Solvency Ratio | -15.34 | -11.74 | -4.73 | -4.68 | -8.18 |
| Operating Cash Flow Ratio | -14.73 | -8.54 | -4.63 | -4.42 | -8.54 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 4.26M | $ 5.31M | $ 2.23M | $ 5.78M | $ 4.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.82 | 1.08 | 1.66 | 1.06 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.01 | 1.48 | 0.30 | 2.88 | 3.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 87.58% | 100.00% | 52.14% | 100.00% | 82.52% |
| EBT Per EBIT | 98.53% | 95.22% | 90.94% | 98.97% | 99.83% |
| Return on Assets (ROA) | -61.08% | -38.15% | -33.48% | -33.81% | -45.79% |
| Return on Equity (ROE) | -63.61% | -69.52% | -36.03% | -56.02% | -48.51% |
| Return on Capital Employed (ROCE) | -73.72% | -41.41% | -75.98% | -36.81% | -58.89% |
| Return on Invested Capital (ROIC) | -64.56% | -41.41% | -39.61% | -36.81% | -48.59% |
| Return on Tangible Assets | -61.08% | -38.15% | -33.48% | -33.81% | -45.79% |
| Earnings Yield | -15.28% | -11.45% | -9.52% | -10.43% | -14.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -120695.08 | -23013.67 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 120695.08 | 23013.67 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -537.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -537.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -14.68% | -8.33% | -9.31% | -9.83% | -15.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.67 | -8.73 | -10.51 | -9.59 | -6.79 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 4.16 | 6.07 | 3.79 | 5.37 | 3.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.81 | -12.01 | -10.74 | -10.17 | -6.50 |
| Price-to-Operating Cash Flow Ratio | -6.81 | -12.01 | -10.74 | -10.17 | -6.51 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.47 | 0.11 | 0.35 | 0.82 |
| Enterprise Value Multiple | -4.63 | -7.25 | -5.17 | -6.61 | -2.55 |
| Enterprise Value | 14.56M | 15.19M | 7.97M | 14.07M | 6.06M |
| EV to EBITDA | -4.63 | -7.25 | -5.17 | -6.61 | -2.55 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -5.59 | -9.97 | -10.15 | -7.08 | -2.96 |
| EV to Operating Cash Flow | -5.59 | -9.97 | -10.15 | -7.08 | -2.97 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.12 | 0.00 | 0.48 | 0.00 | 0.17 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 0.88 | 1.00 | 0.52 | 1.00 | 0.83 |
| Interest Burden | 0.99 | 1.00 | 1.00 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.96 | 0.73 | 0.98 | 0.94 | 1.04 |
Currency in AUD